Oral Session 3-7C Malignant Lymphoma: Advese events/Others

[OS3-7C-6] A phase I study of CC-122 in Japanese patients with advanced non-Hodgkin lymphoma or solid tumor

Takaaki Chou¹, Kazuhito Yamamoto², Toshihiko Doi³, Yasuhito Terui⁴, Harumi Kato², Takayuki Hirose¹, Sachiko Seo⁵, Yumi Ogaki⁶, Hiroshi Fujimoto⁶, Tomoko Ohtsu⁶, Kiyohiko Hatake⁷ (1.Department of Hematology Oncology, Niigata Cancer Center Hospital, Niigata, Japan, 2.Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan, 3.Department of Experimental Therapeutics, National Cancer Center Hospital East, Chiba, Japan, 4.Department of Hematology Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan, 5.Department of Hematology and Oncology, National Cancer Center Hospital East, Chiba, Japan, 6.Celgene K. K., Tokyo, Japan, 7.Department of Hematology, International University of Health and Welfare, Mita, Tokyo, Japan)